IRIS
DOTTA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.366
EU - Europa 16.897
AS - Asia 9.293
SA - Sud America 1.493
Continente sconosciuto - Info sul continente non disponibili 746
AF - Africa 577
OC - Oceania 54
Totale 53.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.076
IT - Italia 3.642
GB - Regno Unito 3.283
CN - Cina 3.187
SG - Singapore 2.928
RU - Federazione Russa 2.848
IE - Irlanda 2.048
UA - Ucraina 1.257
BR - Brasile 1.246
SE - Svezia 998
FR - Francia 884
HK - Hong Kong 833
VN - Vietnam 805
DE - Germania 734
FI - Finlandia 507
KR - Corea 484
ZA - Sudafrica 330
IN - India 259
BD - Bangladesh 184
ES - Italia 173
CA - Canada 144
NL - Olanda 113
TR - Turchia 99
NG - Nigeria 84
BE - Belgio 81
MX - Messico 79
AR - Argentina 74
IQ - Iraq 67
JP - Giappone 67
PK - Pakistan 66
PL - Polonia 57
AT - Austria 53
AU - Australia 48
SA - Arabia Saudita 44
ID - Indonesia 41
CI - Costa d'Avorio 39
EC - Ecuador 38
CO - Colombia 33
IR - Iran 33
CL - Cile 30
CZ - Repubblica Ceca 27
JO - Giordania 26
KE - Kenya 24
EG - Egitto 23
MA - Marocco 23
VE - Venezuela 23
CH - Svizzera 21
GR - Grecia 21
LT - Lituania 21
PE - Perù 20
MY - Malesia 19
AE - Emirati Arabi Uniti 18
IL - Israele 17
HU - Ungheria 16
PT - Portogallo 16
RO - Romania 16
DK - Danimarca 15
JM - Giamaica 15
UZ - Uzbekistan 15
PY - Paraguay 14
DZ - Algeria 13
EU - Europa 12
PH - Filippine 12
NP - Nepal 11
BY - Bielorussia 10
CR - Costa Rica 10
ET - Etiopia 9
TH - Thailandia 9
AL - Albania 8
DO - Repubblica Dominicana 8
KG - Kirghizistan 8
BB - Barbados 7
TN - Tunisia 7
AZ - Azerbaigian 6
BO - Bolivia 6
EE - Estonia 6
KZ - Kazakistan 6
LU - Lussemburgo 6
OM - Oman 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
LB - Libano 5
MD - Moldavia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
BG - Bulgaria 4
HN - Honduras 4
KW - Kuwait 4
LV - Lettonia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
AO - Angola 3
BN - Brunei Darussalam 3
CY - Cipro 3
GT - Guatemala 3
Totale 52.638
Salva come PNG Salva come JPEG
Città #
Dallas 3.152
Southend 2.888
Fairfield 2.662
Dublin 2.029
Ashburn 1.855
Houston 1.621
Singapore 1.488
Chandler 1.256
Woodbridge 1.187
Jacksonville 1.002
Seattle 1.001
Wilmington 944
Milan 940
Cambridge 902
Hong Kong 795
Moscow 792
Santa Clara 788
Beijing 747
San Jose 659
Council Bluffs 625
Hefei 573
Ann Arbor 547
Siena 476
Seoul 457
Princeton 455
The Dalles 365
Nanjing 355
Rome 334
Johannesburg 311
New York 298
Los Angeles 275
Helsinki 255
Lauterbourg 250
Florence 248
Ho Chi Minh City 217
Hanoi 189
Boardman 171
Columbus 149
San Diego 145
Munich 137
San Mateo 132
Buffalo 130
Nanchang 124
Málaga 122
São Paulo 112
Shanghai 101
Dong Ket 99
Abuja 80
Figino 77
London 75
Atlanta 71
Changsha 70
Redondo Beach 70
Shenyang 67
Tianjin 60
Orem 59
Chicago 58
Bengaluru 56
Turin 55
Hebei 54
Dearborn 51
Jiaxing 49
Tokyo 49
Kunming 48
Frankfurt am Main 47
Nuremberg 45
Warsaw 45
Zhengzhou 45
San Francisco 43
Toronto 43
Phoenix 42
Brussels 41
Abidjan 39
Chennai 39
Falls Church 38
Montreal 38
Rio de Janeiro 38
Norwalk 37
Turku 37
Brooklyn 36
Guangzhou 36
Naples 36
Da Nang 35
Washington 34
Amsterdam 30
Düsseldorf 30
Belo Horizonte 29
Vienna 29
Fremont 28
Hangzhou 28
Bologna 27
Boston 27
Brasília 27
Izmir 27
Lappeenranta 27
Leuven 27
Amman 26
Baghdad 25
Jinan 25
Ningbo 25
Totale 36.640
Salva come PNG Salva come JPEG
Nome #
Comprehensive sequencing profile and functional analysis of IsomiRs in human pancreatic islets and beta cells 1.272
Markers of beta cell function in type 1 diabetes mellitus 635
Urban diabetes: The case of the metropolitan area of Rome 455
null 398
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 336
Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes 335
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes 330
Acute on chronic limb ischemia: From surgical embolectomy and thrombolysis to endovascular options 324
Dapagliflozin modulates glucagon secretion in an SGLT2-independent manner in murine alpha cells 312
Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes 309
Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging? 309
G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives 308
MicroRNAs as Regulators of Insulin Signaling: Research Updates and Potential Therapeutic Perspectives in Type 2 Diabetes 306
From immunohistological to anatomical alterations of human pancreas in type 1 diabetes: New concepts on the stage 306
Serum Levels of miR-148a and miR-21-5p Are Increased in Type 1 Diabetic Patients and Correlated with Markers of Bone Strength and Metabolism 304
Lymphocyte-derived exosomal microRNAs promote pancreatic β-cell death and may contribute to type 1 diabetes development. 299
Circulating microRNA (miRNA) expression profiling in plasma of patients with gestational diabetes mellitus reveals upregulation of miRNA miR-330-3p 298
Circulating miRNA95 and miRNA190 Are Sensitive Markers for the Differential Diagnosis of Thyroid Nodules in a Caucasian Population. 297
miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes 296
Circulating MicroRNAs as biomarkers of gestational diabetes mellitus: Updates and perspectives 294
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 291
A plasma miR-193b-365 signature combined with age and glycemic status predicts response to Lactococcus lactis-based antigen-specific immunotherapy in new-onset type 1 diabetes 283
Regulatory T-cells from pancreatic lymphnodes of patients with type-1 diabetes express increased levels of microRNA miR-125a-5p that limits CCR2 expression 282
MicroRNA expression analysis of in vitro dedifferentiated human pancreatic islet cells reveals the activation of the pluripotency-related microRNA cluster miR-302s 271
Analytical performance of free testosterone calculated by direct immunoluminometric method compared with the Vermeulen equation: results from a clinical series 270
Analysis of posttransplant diabetes mellitus prevalence in a population of kidney transplant recipients. 270
Islet-reactive CD8+T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors 268
MicroRNA miR-124a, a negative regulator of insulin secretion, is hyperexpressed in human pancreatic islets of type 2 diabetic patients 268
MicroRNA expression profiles of human iPSCs differentiation into insulin-producing cells 264
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial 262
Chronic kidney disease in type 2 diabetes: Lessons from the Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicentre Study 261
Putative endothelial progenitor cells predict long-term mortality in type-2 diabetes 258
Prognostic bioindicators in severe COVID-19 patients 258
Clinical significance of nonalbuminuric renal impairment in type 2 diabetes 254
Conventional and Neo-Antigenic Peptides Presented by β Cells Are Targeted by Circulating Naïve CD8+ T Cells in Type 1 Diabetic and Healthy Donors 252
HbA1c Variability As an Independent Correlate of Nephropathy, but Not Retinopathy, in Patients With Type 2 Diabetes: The Renal Insufficiency And Cardiovascular Events (RIACE) Italian Multicenter Study 250
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 249
MicroRNA profiling in sera of patients with type 2 diabetes mellitus reveals an upregulation of miR-31 expression in subjects with microvascular complications 249
Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes 249
Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes. 249
Dual energy CT in gland tumors: a comprehensive narrative review and differential diagnosis 248
Delta-cell specific expression of Hedgehog pathway Ptch1 receptor in murine and human endocrine pancreas 245
MicroRNAs: markers of β-cell stress and autoimmunity 245
A new solid-phase radioimmunoassay to detect anti-GAD65 autoantibodies 243
A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes 242
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 241
Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy 240
Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus 239
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p regulate the expression of proapoptotic bh3-only proteins DP5 and PUMA in human pancreatic β-cells 236
Anti-ganglioside antibodies in new onset type 1 diabetic patients and high risk subjects 234
An overview of pancreatic beta-cell defects in human type 2 diabetes: implications for treatment 234
A three-layer perspective on miRNA regulation in β cell inflammation 232
A novel neuroendocrine cell surface glycoprotein: identification, isolation, and initial characterization 232
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study 231
Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II 231
Endocrine actions of osteocalcin 230
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial 228
Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells 228
The Landscape of microRNAs in βCell: between phenotype maintenance and protection 228
T-cell mediated autoimmunity to the insulinoma-associated protein 2 islet tyrosine phosphatase in type 1 diabetes mellitus. 227
Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study 227
Analysis of post-transplant diabetes mellitus (PTDM) prevalence in a population of kidney transplant recipients 225
A prozone phenomenon interferes in islet cell antibody detection: direct comparison of two methods in subjects at risk of diabetes and in insulin dependent diabetics at onset 225
Prevention and treatment of autoimmune diseases with plant virus nanoparticles 225
Screening and detecting significant liver fibrosis in patients with NAFLD: A practical approach using non-invasive tests 224
Pancreatic Alpha-Cells Contribute Together With Beta-Cells to CXCL10 Expression in Type 1 Diabetes 223
MicroRNA-124a is hyperexpressed in type 2 diabetic human pancreatic islets and negatively regulates insulin secretion 221
Coxsackieviruses and Insulitis 220
Intra-islet insulin synthesis defects are associated with endoplasmic reticulum stress and loss of beta cell identity in human diabetes 219
GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva 218
12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients 215
Oral delivery of Glutamic Acid Decarboxylase (GAD)-65 and IL10 by Lactococcus lactis reverses diabetes in recent-onset NOD mice. 215
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study 215
Serum transforming growth factor β1 during diabetes development in non-obese diabetic mice and humans 213
Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2. 213
Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside 212
Telecare Provides comparable efficacy to conventional self-monitored blood glucose in patients with type 2 diabetes titrating one injection of insulin glulisine-the ELEONOR study 212
Primary ovarian insufficiency due to steroidogenic cell autoimmunity is associated with a preserved pool of functioning follicles. 211
Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10-Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells 210
Beyond glycemic control in diabetes mellitus: effects of incretin-based therapy on bone metabolism 209
Angiotensin I-converting enzyme type 2 expression is increased in pancreatic islets of type 2 diabetic donors 208
Non-coding RNAs: novel players in insulin resistance and related diseases 208
Acute onset of seeming IDDM in an AIDS patient 208
Autoantibodies to the GM2-1 islet ganglioside and to GAD-65 at type 1 diabetes onset 207
Circulating microRNAs signature for predicting response to GLP1-RA therapy in Type 2 diabetic patients: a pilot study 206
The essential role of microRNAs in Diabetes Mellitus: regulators of β cell function and potential disease biomarkers 206
La prevenzione del diabete mellito di tipo 1 205
Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes 205
Guidelines for the treatment and management of new-onset diabetes after transplantation 203
MicroRNA circolanti come biomarcatori per il diabete mellito di tipo 2: avanzamenti e prospettive future 202
Assay for cytoplasmic islet cell antibodies using two-color immunofluorescence and rat pancreas 202
Serum Proteomic Profile of Asthmatic Patients after Six Months of Benralizumab and Mepolizumab Treatment 201
Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. 200
Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial 200
Incretin Hormones and Beta-cell mass expansion: what we know and what is missing? 200
Suppressor of cytokine signaling gene expression in human pancreatic islets: modulation by cytokines. 199
Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells 198
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease 197
Application of phage display peptide library to autoimmune diabetes: identification of IA-2/ICA512bdc dominant autoantigenic epitopes 194
Viral Infections and diabetes 194
Totale 26.090
Salva come PNG Salva come JPEG
Categoria #
all - tutte 161.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 161.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.036 0 556 209 289 117 101 173 105 145 317 320 704
2022/20234.482 282 318 472 645 475 929 66 353 474 165 192 111
2023/20243.121 149 109 245 133 160 843 967 99 25 124 39 228
2024/20256.875 133 387 620 430 741 347 219 467 659 329 675 1.868
2025/202616.813 1.262 2.233 2.626 1.549 2.531 623 1.702 695 743 887 495 1.467
2026/20271.265 793 472 0 0 0 0 0 0 0 0 0 0
Totale 53.426